Objective: Cysteinyl leukotrienes (Cys-LTs) are proinflammatory lipid mediators generated from arachidonic acid through 5-lipoxygenase (5-LO). It was reported that the 5-LO pathway is associated with vascular smooth muscle cell (VSMC) proliferation and migration; however, the relationship between Cys-LTs and VSMC proliferation and migration remains unclear. Methods: We used a mouse (C57/BL6J) model of femoral artery wire injury, and compared neointimal formation between controls and animals treated with the Cys-LT receptor antagonist, Montelukast (3 mg/kg/day). The effects of Cys-LTs with or without Montelukast on mouse aortic VSMC proliferation and migration were also investigated. Results: After wire injury, neointimal hyperplasia was observed, and immunohistochemical analysis demonstrated expression of the Cys-LT receptors (Cys-LT 1 and Cys-LT 2 ) and α-smooth muscle actin in the injured arterial walls. RT-PCR analysis revealed that transcription was not altered during the observation period (before, 1, 2 and 4 weeks after injury). Administration of Montelukast significantly inhibited neointimal formation 4 weeks after injury (intima/media ratio; control group 1.94 ± 0.56 versus Montelukast-treated group 0.94 ± 0.26, n = 11, P b 0.001). In an in vitro study, LTD 4 , but not LTC 4 and LTE 4 significantly stimulated VSMC proliferation (1000 nM), and this effect was inhibited by Montelukast (10 μM). LTC 4 , LTD 4 and LTE 4 significantly stimulated VSMC migration (1000 nM), and this effect was inhibited by Montelukast (10 μM). Conclusions: Our data suggest that Cys-LTs are involved in VSMC proliferation and migration, and a Cys-LT receptor antagonist may have beneficial effects on vascular remodeling after mechanical injury.
Introduction
Leukotrienes are proinflammatory lipid mediators generated from arachidonic acid [1] [2] [3] . There are two types of leukotrienes, cysteinyl leukotrienes (Cys-LTs) and leukotriene B 4 (LTB 4 ), which are generated through 5-lipoxygenase (5-LO) assisted by 5-LO-activating protein (FLAP) . The signals of Cys-LTs, including LTC 4 , LTD 4 and LTE 4, are primarily transduced through high-affinity G protein-coupled receptors, Cys-LT 1 and Cys-LT 2 [4] . Cys-LT 1 is highly expressed in peripheral blood leukocytes, lung and spleen, whereas Cys-LT 2 is expressed in heart and brain [5] . As Cys-LTs triggers a variety of tissue responses, including increases in vascular permeability and airway smooth muscle constriction [6, 7] , Cys-LT receptor antagonists are useful in the treatment of allergic diseases including asthma [8, 9] . It was reported that Pranlukast, a Cys-LT receptor antagonist, suppresses the production of inflammatory cytokines in peripheral Cardiovascular Research 76 (2007) 160 -166 www.elsevier.com/locate/cardiores blood mononuclear cells of patients with bronchial asthma [8] . These drugs have been shown to be useful in the oral treatment of bronchial asthma. In several investigations, Montelukast, another Cys-LT receptor antagonist, reduced airway smooth muscle cell remodeling in a mouse model of chronic allergic airway inflammation [10] . Recently, the 5-LO pathway was reported to be involved in atherogenesis and arteriosclerosis. Genetic studies have revealed an association between the 5-LO pathway and human cardiovascular disease [11, 12] . The expression of 5-LO is also associated with atherosclerotic plaque instability and formation of aortic aneurysms [13, 14] . An association between LTB 4 and vascular smooth muscle cell (VSMC) proliferation and migration [15] [16] [17] [18] [19] , which play important roles in the development of arteriosclerosis, has also been reported [20, 21] . However, the relationship between Cys-LTs and arteriosclerosis, VSMC proliferation and migration remains unclear. To prevent the progression of arteriosclerosis, these relationships need to be determined.
In this paper, we investigated the expression of Cys-LT receptors in VSMCs in vivo, and elucidated the effects of Cys-LTs on VSMC proliferation and migration in vitro. Furthermore, we used a mouse model of femoral artery wire injury and investigated the effect of Montelukast, a Cys-LT receptor antagonist, on neointimal formations after wire injury.
Methods

Mouse femoral artery injury model
The experimental protocols were approved by the Institutional Animal Care and Use Committee, Faculty of Medicine, Tottori University, and conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). All the procedures were performed in accordance with the Tottori University animal care guidelines. Adult male 8-weekold C57BL/6J mice were purchased from CLEA Japan, Inc (Tokyo, Japan), and maintained in an animal facility in a room with a 12-h light/dark cycle and free access to normal chow and water. All the mice were anesthetized by an intraperitoneal injection of a cocktail of ketamine HCl (80 mg/kg, Sankyo, Tokyo, Japan) and xylazine (5 mg/kg, Bayer, Tokyo, Japan). Transluminal arterial injury was induced by inserting a straight wire (0.38 mm in diameter, Whisper, Guidant, Santa Clara, CA, USA) into the left femoral artery according to the method described by Sata et al. [22] . The wire was left in the artery for 1 minute to denude and dilate the artery. The mice were assigned to two groups: a control group given 10% Na 2 CO 3 (n = 11) and a group treated with Montelukast (Wako, Osaka, Japan) (n = 11), a Cys-LT receptor antagonist. Montelukast (3 mg/kg/day) or control vehicle were infused subcutaneously for 4 weeks using an Alzet Model 2004 mini osmotic pumps (6 μl/day delivery rate; Alza Corporation, Mountain View, CA, USA) immediately after injury. Blood pressure was measured on conscious restrained mice by tail-cuff plethysmography (KN-214 II; Natsume, Tokyo, Japan) before and after 1, 2, 3 and 4 weeks administration of Montelukast. Four weeks after injury, the mice were perfused with 4% paraformaldehyde (Wako, Osaka, Japan) in PBS (pH 7.4). The femoral artery was carefully excised, embedded in Tissue-Tek OCT compound (Japan Sakura, Tokyo, Japan), and quick frozen in liquid nitrogen. The artery was sectioned in 10 μm-thickness sections and stained with Victoria blue, hematoxylin and eosin (Muto, Tokyo, Japan). Images of 5 mid-femoral sections were captured on a CCD camera (Nikon, Tokyo, Japan), and the neointimal and medial areas were determined with the aid of a digital image analyzer, Scion image (Scion Corporation, Frederick, MI, USA). Immunohistochemical analysis was performed with antibodies to identify Cys-LT 1 receptors, Cys-LT 2 receptors (Santa Cruz Biotechnology, Santa Cruz, CA, USA), α-smooth muscle actin (Sigma, St. Louis, MO, USA), MOMA-2 (BMA Biomedicals, AG, Switzerland). Antibody distribution was visualized by the avidin-biotin complex technique and substrates (Vector Laboratories, Burlingame, CA, USA). The sections were counterstained with hematoxylin.
RNA Isolation and RT-PCR
To isolate total RNA, the mice with injured femoral arteries were perfused with PBS and the injured and contra-lateral noninjured femoral artery was quickly excised (n = 3). The injured arteries were collected at 1, 2 and 4 weeks after wire injury. Extraction of total RNA was performed by using the RNeasy Mini kit (Qiagen, Valencia, CA, USA) including an on-column DNase digestion step. The PCR primers were as follows: Cys-LT 1 forward primer sequence, CAACGAACTATCCACCTT-CACC; Cys-LT 1 reverse primer sequence, AGCCTTCTCC-TAAAGTTTCCAC; Cys-LT 2 forward primer sequence, GTC CACGTGCTGCTCATAGG, Cys-LT 2 reverse primer sequence, ATTGGCTGCAGCCATGGTC, glyceraldehydes-3-phosphate dehydrogenase (GAPDH) forward primer sequence, ACCACAGTCCATGCCATCAC, GAPDH reverse primer sequence, TCCACCACCCTGTTGCTGTA. The GAP DH PCR reactions were as follows: 94°C, 15 s, 54°C, 30 s, 72°C, 1 min, for 22 cycles. The Cys-LT 1 and Cys-LT 2 PCR reactions were as follows: 94°C, 5 min; then 94°C, 1 min, 65°C for Cys-LT 1 , 68°C for Cys-LT 2 , 1 min; 72°C, 45 s, for 30 cycles; and 72°C 10 min to end the reaction [23] . In our preliminary experiments of RT-PCR analysis, we amplified the mRNA of GAPDH for 18, 20, 22, 24 and 30 cycles, and Cys-LT receptors for 24, 28, 30, 32 and 34 cycles. On the basis of the results of these preliminary experiments, we selected 22 cycles for GAPDH and 30 cycles for Cys-LT receptors as the most suitable amplification cycles for quantifying transcription.
Vascular smooth muscle cells proliferation and migration in vitro
Murine aortic VSMCs were isolated from 8-week-old mice, washed in PBS, and incubated in Dulbecco's modified Eagle's Medium (DMEM) containing 1 mg/ml of type 2 collagenase (Wako, Tokyo, Japan) for 15 min. Then the adventitia was removed with fine forceps, and the vessels incised longitudinally. The vessels were incubated further in DMEM with 1 mg/ml of type 1 collagenase (Wako, Tokyo, Japan) and 0.125 mg/ml of elastase type 3 (Sigma, St. Louis, MO, USA) for 1 h [24] . Finally, the cells were cultured in DMEM with 20% fetal calf serum (FCS), penicillin (200 U/ ml), streptomycin (200 μg/ml), and were used in the following experiment. The cultured VSMCs were confirmed by positive staining with monoclonal antibodies against mouse α-smooth muscle actin (Sigma, St. Louis, MO, USA). VSMCs (5000 cells/well) were plated in 96-well plates in 10% FCS/DMEM. After 24 h, the cells were starved by serum deprivation for another 48 h in 0.4% FCS/DMEM. Following the starvation, the cells were stimulated, with or without Cys-LTs (LTC 4 , LTD 4 and LTE 4 ) (Cayman Chemical, Ann Arbor, MI, USA) in 0.4% FCS/DMEM (0.1, 10 and 1000 nM). After 48 h, the cells were counted using Cell Titer 96 Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA) according to the manufacturer's instructions. In another set of experiments, VSMCs were incubated with or without Montelukast (0.1, 1.0 and 10 μM) following stimulation by LTD 4 (1000 nM) for 48 h.
VSMCs (20,000 cells/well) were added to the upper wells of a 96-well Boyden Chamber that were separated with a polycarbonate filter (8-μm pores, Neuro Probe, Gaithersburg, MD, USA), and Cys-LTs were added to the bottom wells. After incubation for 6 h, the membranes were fixed and stained by Diff-Quik (Sysmex, Kobe, Japan). The number of migrated cells in 5 random fields was counted in each well. 
murine macrophages isolation and Cys-LTs immunoassay
Murine macrophages were harvested from 8-week-old mice by washing the peritoneal cavity with RPMI-1640 media supplemented with 0.4% FCS. Peritoneal cells were washed 3 times in RPMI-1640 media supplemented with 0.1% endotoxin-free bovine serum albumin (BSA). Murine macrophages and VSMCs were stimulated with or without 1.0 μg/ml lipopolysaccharide (LPS) (Sigma, St. Louis, MO, USA) for 6 h and 5 μM Ca ionophore A23187 (Sigma, St. Louis, MO, USA) for 10 min. Cys-LTs in the supernatants were measured by enzyme immunoassay employing a cysteinyl leukotriene polyclonal antiserum (Cayman Chemical, Ann Arbor, MI, USA).
Statistical analysis
All data are expressed as the mean ± SD. To assess the difference between 2 groups with equal variance, the data were analyzed using Student's t-test. Otherwise, the data were analyzed using ANOVA and Mann-Whitney's U test. StatView software version 5 for Windows (SAS Institute Inc., Cary, NC, USA) was used for all statistical analyses. A value of P b 0.05 was considered statistically significant.
Results
Cys-LT 1 and Cys-LT 2 are expressed in VSMCs in injured arteries
Neointimal hyperplasia was observed in the injured femoral arteries 4 weeks after injury. The injured arteries expressed Cys-LT 1 , Cys-LT 2 and α-SMA (Fig. 1) . The noninjured artery also expressed Cys-LT 1 and Cys-LT 2 . These results suggested that Cys-LT 1 and Cys-LT 2 were expressed in mice VSMC. MOMA-2 was detected in the injured site 5 days after wire injury, suggesting that macrophage infiltrate into the vascular wall during the acute inflammatory phase.
RT-PCR was used to elucidate Cys-LT 1 and Cys-LT 2 transcription during the formation of neointimal hyperplasia. Cys-LT 1 and Cys-LT 2 were expressed constitutively at the same level in all specimens collected before and after wire injury (1, 2 and 4 weeks). They were also expressed in the contra-lateral non-injured artery, with expression being comparable to that observed in the injured arteries (Fig. 2) . These results indicated that Cys-LT 1 and Cys-LT 2 mRNA levels were not altered during the formation of neointimal hyperplasia.
Murine macrophages produced Cys-LTs
The production of Cys-LTs by macrophages during stimulation with LPS and A23187 was significantly higher than in controls (LPS; 2.31 ± 1.15 ng/ml, A23187; 5.58 ± 2.61 ng/ml and 0.4% FBS in RPMI; 0.02 ± 0.01 ng/ml, each n = 4, P b 0.05). However, the production of Cys-LTs by VSMCs during stimulation was not detectable (data not shown). These results suggested that murine macrophages produced Cys-LTs following stimulation by LPS and A23187, whereas VSMCs did not.
The effects of Cys-LTs on VSMC proliferation and migration in vitro
We investigated mice VSMC proliferation after 48 h of stimulation with LTC 4 , LTD 4 and LTE 4 . LTD 4 significantly stimulated VSMC proliferation at 1000 nM (each n = 5, P b 0.05 compared to control), but not at 0.1 nM and 10 nM (each n = 5) (Fig. 3A . LTC 4 and LTE 4 did not stimulate at any dose (each n = 5) (data not shown). The effect of LTD 4 on VSMC proliferation was inhibited by Montelukast at 10 μM (each n = 5, P b 0.05), but not at 0.1 μM and 1.0 μM (Fig. 3B) .
Montelukast did not inhibit VSMC proliferation induced by 10% FCS (each n = 5) (data not shown).
LTC 4 , LTD 4 and LTE 4 significantly stimulated VSMC migration at 1000 M, the same dose that stimulated VSMC proliferation (each n = 3, P b 0.05 compared to the control) (Fig. 4) . These stimulatory effects were inhibited by Montelukast at 10 μM (each n = 3, P b 0.05) (Fig. 4) . Montelukast did not inhibit the effect of 10% FCS on VSMC migration (each n = 3) (data not shown).
The effect of Montelukast on mice neointimal hyperplasia formation after wire injury
Administration of Montelukast significantly inhibited neointimal formation 4 weeks after injury (intimal area; control group 0.33± 0.1 mm 2 versus Montelukast-treated group 0.14± 0.006 mm 2 , each n =11, P b 0.001) (Fig. 5F ). The intima/ media ratio of the Montelukast-treated group was smaller than the control group (intima/media ratio; control group 1.94 ± 0.56 versus Montelukast-treated group 0.94± 0.26, each n =11, P b 0.001) (Fig. 5E ). There was no significant difference in body weight between the control and Montelukast-treated group before and after wire injury (data not shown). Blood pressure levels in the mice were similar before and after administration of Montelukast (data not shown).
Discussion
We showed that Cys-LTs stimulated murine VSMC proliferation and migration, and that Montelukast, a Cys-LT receptor antagonist, inhibited the effects of Cys-LTs in vitro. In addition, Montelukast reduced neointimal hyperplasia in a murine model of vascular wire injury in vivo. Our data suggests Cys-LTs are involved in murine VSMC proliferation and migration through their receptors. Therefore, Montelukast may have beneficial effects on vascular remodeling after mechanical injury.
VSMCs are a major component of the arterial wall. In normal arteries, VSMCs contribute to the maintenance of vascular tone and blood pressure. In injured arteries, VSMC proliferation and migration are important processes in the development of arteriosclerosis and also in neointimal hyperplasia after transluminal angioplasty [25] . As it is necessary to suppress arteriosclerosis in order to decrease morbidity and mortality from cardiovascular diseases, it is important to elucidate the mechanisms of VSMC proliferation and migration.
To investigate the roles of Cys-LTs and the expression of Cys-LT receptors in VSMCs in vivo, we used a mouse model of femoral artery wire injury. As this model results in proliferation and migration of VSMCs, it should be useful for investigating the mechanism of vascular remodeling after percutaneous coronary intervention. Cys-LTs are the downstream products of the 5-LO reaction and they are known to function as potent chemoattractants and proinflammatory mediators in the pathogenesis of several inflammatory diseases. An association between LTB 4 and arteriosclerosis has been reported [18, 19] : however, an association between arteriosclerosis and the other down-stream products of the 5-LO reaction, the Cys-LTs, has not been investigated.
Our in vivo results showed that Cys-LT 1 and Cys-LT 2 were expressed in murine VSMCs, and that the expressions were comparable during vascular remodeling (before, 1, 2 and 4 weeks after wire injury). In this model, it was reported that proliferating cells were identified in the neointimal area at 1 and 2 weeks after wire injury [22, 26] . Our study is the first report demonstrating that Cys-LT receptors are expressed constitutively in the arterial wall.
We also investigated the role of Cys-LT 1 and Cys-LT 2 in murine VSMC in vitro. Cys-LTs are produced mainly by leukocytes and endothelial cells [1] [2] [3] [4] and bind to Cys-LT receptors (Cys-LT 1 and Cys-LT 2 ), to produce their biological effects [6] . Our in vitro study showed that LTD 4 , but not LTC 4 or LTE 4 , stimulated proliferation of murine VSMCs, and that the effect of LTD 4 was inhibited by its receptor antagonist, Montelukast. These results are consistent with previous observations showing that LTD 4 was more active on VSMC than LTC 4 [27, 28] , and also suggested that LTD 4 plays a role in VSMC proliferation through Cys-LT receptors. In contrast, in our VSMC migration study, LTC 4 , LTD 4 and LTE 4 stimulated VSMC migration, with these effects being inhibited by Montelukast. Although we did not explore the differences in the mechanism of VSMC proliferation and migration through Cys-LT receptors, our results suggested that Cys-LTs are potent mitogen and chemotaxic agents. It was reported that LTD 4 induced IL-1β expression in rat VSMC, whereas LTC 4 had no such effect [28] . Further investigations are therefore needed to elucidate the differences in the effects of LTC 4 , LTD 4 and LTE 4 .
There is evidence that inflammatory cells play important roles in vascular remodeling [29] . Our results confirmed that murine macrophages exist at the injured site 5 days after wire injury. Also, macrophages but not VSMCs, produced Cys-LTs following stimulation by LPS and A23187. Our results suggested inflammatory cells have an important role of producing Cys-LTs in the early phase of vascular remodeling.
Our in vivo study showed that Montelukast inhibited neointimal formation in murine femoral arteries after vascular injury. It has been reported that MK-571, a specific LTD 4 receptor antagonist, significantly reduced neointimal hyperplasia following balloon catheter injury in a rat carotid artery model and also that Cys-LTs, specifically LTD 4 , stimulated rat VSMC proliferation [27] . However, in our VSMC migration study, LTC 4 , LTD 4 and LTE 4 stimulated VSMC migration and these effects were inhibited by Montelukast. Therefore, the inhibitory effect of Montelukast on neointimal formation may be due not only to suppression of VSMC proliferation, but also to VSMC migration. Therefore, it is possible an unselective antagonist against Cys-LT receptors may be more effective than specific Cys-LT receptor antagonists. These results suggested that Cys-LTs stimulated arterial remodeling after vascular injury through Cys-LT receptors.
A limitation of our study was that we could not distinguish the roles and importance of Cys-LT 1 and Cys-LT 2 on VSMC proliferation and migration. Montelukast is used as a Cys-LT 1 antagonist but not as a Cys-LT 2 antagonist in humans. However, Ogasawara et al. reported that the affinity of a Cys-LT receptor antagonist had a different affinity in mice compared to humans [30] . A recent study reported that mouse Cys-LT receptor expression is different from human Cys-LT receptor expression in several tissues [31] . Therefore, the effect of Montelukast on VSMC remodeling should be extrapolated cautiously to the clinical setting. We need to further explore this question: however, our findings demonstrating the involvement of Cys-LTs in murine vascular remodeling are very important.
In conclusion, our study showed for the first time an association between Cys-LTs, and VSMC proliferation and migration. VSMC proliferation and migration are important processes in the development of arteriosclerosis. Further detailed investigations are necessary in order to minimize the morbidity and mortality of cardiovascular diseases due to arteriosclerosis.
